Literature DB >> 16877418

Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.

Hem Kumar Tewari1, Ritu Gadia, Deepak Kumar, Pradeep Venkatesh, Sat Pal Garg.   

Abstract

PURPOSE: This case-control study was conducted to evaluate autonomic function activity and reactivity in patients with central serous chorioretinopathy (CSCR), because stress and type A personality, known risk factors, are also related to autonomic nervous system activity.
METHODS: Patients with CSCR were selected from the outpatient department and medical retina services in one center. Control subjects were chosen from the healthy subjects of similar age group. The autonomic activity (both sympathetic and parasympathetic) in 45 patients with CSCR was evaluated and compared with that in 28 healthy control subjects, by using HRV (heart rate variability) analysis according to the guidelines laid down by the Task Force of European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996). Autonomic reactivity (both sympathetic and parasympathetic) was also evaluated in 32 patients with CSCR and compared with that in 28 healthy control subjects, by using standard autonomic function tests: HRV, as a measure of the resting sympathetic and parasympathetic activity (tone), and changes in blood pressure response and heart rate changes during various stressor stimuli in the tests as a measure of sympathetic and parasympathetic reactivity.
RESULTS: Patients with CSCR showed significantly decreased parasympathetic activity (P = 0.002), significantly increased sympathetic activity (P = 0.005), and significantly increased sympathetic-parasympathetic balance (P = 0.004) as measured from different measures of beat-to-beat heart rate variability. The patients also showed significantly decreased parasympathetic reactivity (P = 0.03). Sympathetic reactivity showed a trend toward lessening.
CONCLUSIONS: Autonomic function, both activity and reactivity components of sympathetic and parasympathetic system, is impaired in patients with CSCR. Because autonomic supply modulates the choroidal blood flow, there may be a correlation between measures of autonomic function and the presence of CSCR.

Entities:  

Mesh:

Year:  2006        PMID: 16877418     DOI: 10.1167/iovs.05-1246

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

2.  Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.

Authors:  Gülizar Demirok; Fatih Kocamaz; Yasemin Topalak; Yeşim Altay; Ahmet Sengun
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

Review 3.  Attenuation of age- and sucrose-induced insulin resistance and syndrome X by a synergistic antioxidant cocktail: the AMIS syndrome and HISS hypothesis.

Authors:  W Wayne Lautt; Zhi Ming; Dallas J Legare
Journal:  Can J Physiol Pharmacol       Date:  2010-03       Impact factor: 2.273

4.  Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy.

Authors:  Bert Müller; Janina Tatsios; Jan Klonner; Daniel Pilger; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-06       Impact factor: 3.117

5.  First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy.

Authors:  Timothy Y Y Lai; Ricky Y K Lai; Jasmine W S Ngai; Wai-Man Chan; Haitao Li; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2007-08-29       Impact factor: 2.379

6.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

7.  Role of Avastin in management of central serous chorioretinopathy.

Authors:  Shaaban A Mehany; Ahmad M Shawkat; Mohamed F Sayed; Khaled M Mourad
Journal:  Saudi J Ophthalmol       Date:  2010-10-04

8.  HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail.

Authors:  W Wayne Lautt; Zhi Ming; M Paula Macedo; Dallas J Legare
Journal:  Exp Gerontol       Date:  2008-04-27       Impact factor: 4.032

9.  Is myopia a protective factor against central serous chorioretinopathy?

Authors:  George J Manayath; Saurabh Arora; Hardik Parikh; Parag K Shah; Sarvesh Tiwari; Venkatapathy Narendran
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

10.  Relationship between mean platelet volume and central serous chorioretinopathy.

Authors:  Ayhan Dursun; Mustafa Ilker Toker; Ayşe Vural Ozec; Erman Bozali; Kadir Kirboga; Feyza Gulac Dursun; Haydar Erdogan; Aysen Topalkara; Mustafa Kemal Arici
Journal:  Int Ophthalmol       Date:  2016-04-25       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.